RESTEM to Present at BIO International Convention
Summary
RESTEM announced that its CEO will present at the 2026 BIO International Convention in San Diego. The company plans to use the event for corporate presentations and one-on-one meetings. RESTEM positions itself as a clinical-stage biotechnology company developing off-the-shelf cell therapies for autoimmune, inflammatory, and age-related diseases. The announcement also highlights its interest in meeting investors, strategic partners, and business development professionals.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected